Physician profile
Katrin Lalezarzadeh
NPI 1942414024
$2,250.72
in general payments reported to CMS, 2019-2025
19 companies · $494 in 2025
The $494 reported for 2025 was more than what 93% of Hospice and Palliative Medicine (Pediatrics) providers received nationally (typical 2025 total: $50.56).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $233 · 2021: $295 · 2022: $321 · 2023: $216 · 2024: $412 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $349.34 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $247.80 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $224.89 | 2019-2025 | Enflonsia, Vaxneuvance, Proquad |
| Glaxosmithkline, LLC. | $215.19 | 2020-2025 | Bexsero, Pediarix |
| Novo Nordisk INC | $198.13 | 2024 | Wegovy |
| Sanofi Pasteur INC. | $167.26 | 2019-2025 | |
| Cranial Technologies, INC | $160.51 | 2019-2025 | Doc Band |
| Axsome Therapeutics, INC. | $134.55 | 2025 | Auvelity |
| Amarin Pharma, INC. | $124.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $85.63 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.54 | 2020-2021 | |
| Tris Pharma INC | $76.22 | 2019-2022 | |
| Phadia US INC. | $37.89 | 2023-2025 | Immunocap |
| Seqirus USA INC | $36.04 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $33.85 | 2025 | Daybue |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $28.65 | 2025 | Alvesco |
| Ars Pharmaceuticals Operations, INC. | $24.77 | 2025 | Neffy |
| Shire North American Group INC | $14.82 | 2019 | |
| Genentech USA, INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrin Lalezarzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.